» Articles » PMID: 24292992

Predicting the Restricted Mean Event Time with the Subject's Baseline Covariates in Survival Analysis

Overview
Journal Biostatistics
Specialty Public Health
Date 2013 Dec 3
PMID 24292992
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

For designing, monitoring, and analyzing a longitudinal study with an event time as the outcome variable, the restricted mean event time (RMET) is an easily interpretable, clinically meaningful summary of the survival function in the presence of censoring. The RMET is the average of all potential event times measured up to a time point τ and can be estimated consistently by the area under the Kaplan-Meier curve over $[0, \tau ]$. In this paper, we study a class of regression models, which directly relates the RMET to its "baseline" covariates for predicting the future subjects' RMETs. Since the standard Cox and the accelerated failure time models can also be used for estimating such RMETs, we utilize a cross-validation procedure to select the "best" among all the working models considered in the model building and evaluation process. Lastly, we draw inferences for the predicted RMETs to assess the performance of the final selected model using an independent data set or a "hold-out" sample from the original data set. All the proposals are illustrated with the data from the an HIV clinical trial conducted by the AIDS Clinical Trials Group and the primary biliary cirrhosis study conducted by the Mayo Clinic.

Citing Articles

Modeling the Restricted Mean Survival Time Using Pseudo-Value Random Forests.

Schenk A, Basten V, Schmid M Stat Med. 2025; 44(5):e70031.

PMID: 39985373 PMC: 11846141. DOI: 10.1002/sim.70031.


Optimal Machine Learning Models for Developing Prognostic Predictions in Patients With Advanced Cancer.

Hamano J, Takeuchi A, Keyaki T, Nose H, Hayashi K Cureus. 2025; 16(12):e76227.

PMID: 39845249 PMC: 11751371. DOI: 10.7759/cureus.76227.


-Inflated Beta Regression Model for Estimating -Restricted Means and Event-Free Probabilities for Censored Time-to-Event Data.

Wang Y, Murray S Biom J. 2024; 66(8):e70009.

PMID: 39607310 PMC: 11604032. DOI: 10.1002/bimj.70009.


Beyond hazard ratios: appropriate statistical methods for quantifying the clinical effectiveness of immune-oncology therapies - the example of the Netherlands.

Corro Ramos I, Qendri V, Al M BMC Med Res Methodol. 2024; 24(1):260.

PMID: 39478443 PMC: 11523788. DOI: 10.1186/s12874-024-02373-5.


Impact of complementary health approaches on opioid prescriptions among veterans with musculoskeletal disorders - A retrospective cohort study.

Han L, Goulet J, Skanderson M, Redd D, Brandt C, Zeng-Treitler Q J Pain. 2024; 26:104695.

PMID: 39384145 PMC: 11781976. DOI: 10.1016/j.jpain.2024.104695.


References
1.
Hammer S, Squires K, Hughes M, Grimes J, Demeter L, Currier J . A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997; 337(11):725-33. DOI: 10.1056/NEJM199709113371101. View

2.
Chen P, Tsiatis A . Causal inference on the difference of the restricted mean lifetime between two groups. Biometrics. 2002; 57(4):1030-8. DOI: 10.1111/j.0006-341x.2001.01030.x. View

3.
Rudser K, LeBlanc M, Emerson S . Distribution-free inference on contrasts of arbitrary summary measures of survival. Stat Med. 2012; 31(16):1722-37. DOI: 10.1002/sim.4505. View

4.
Royston P, Parmar M . The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Stat Med. 2011; 30(19):2409-21. DOI: 10.1002/sim.4274. View

5.
B Gilbert P, Wei L, Kosorok M, Clemens J . Simultaneous inferences on the contrast of two hazard functions with censored observations. Biometrics. 2002; 58(4):773-80. DOI: 10.1111/j.0006-341x.2002.00773.x. View